Roche's R&D efficiency is below other pharma giants

Cumulated R&D expenses vs number of FDA novel drug approvals, top pharmaceutical companies, 2015-2023

One way to read this graph: Roche has spent more on R&D than Novartis or Pfizer for less FDA approvals.
Chart: ptur Source: FDA (number of new molecular entities approvals), macrotrends.net (R&D expenses), drugs.com (drug names) Get the data
swissinfo.ch